Simultaneously, through in vitro and in vivo experiments, we will continue to investigate the role of KK-LC-1 in tumor immune evasion, T cell activation, and modulation of the tumor microenvironment, providing a theoretical basis for the development of new treatment strategies. Here, CT83 is linked to neoplasm.